187 related articles for article (PubMed ID: 3862881)
21. [Serum and sputum levels of cefotetan used in respiratory tract infections].
Matsumoto Y; Hitsuda Y; Sugimoto Y; Ishikawa J; Sasaki T
Jpn J Antibiot; 1986 Oct; 39(10):2690-4. PubMed ID: 3468274
[TBL] [Abstract][Full Text] [Related]
22. [Transfer of cefmenoxime to burn blister fluids].
Nishizaki A; Aoyama H; Koh T; Izawa Y
Jpn J Antibiot; 1984 Mar; 37(3):295-302. PubMed ID: 6330396
[TBL] [Abstract][Full Text] [Related]
23. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
Matsumoto K; Nagatake T; Uzuka Y; Harada T; Rikitomi N
Chemotherapy; 1983; 29(2):80-8. PubMed ID: 6301776
[TBL] [Abstract][Full Text] [Related]
24. [Clinical evaluation of cefmenoxime (CMX) for complicated urinary tract infection].
Tsuchida S; Sasaki S; Takada H; Miyagata S; Sato S; Shimizu S; Sakamoto F; Kizu N
Hinyokika Kiyo; 1985 Feb; 31(2):365-74. PubMed ID: 3859998
[TBL] [Abstract][Full Text] [Related]
25. [Clinical studies on cefmenoxime in the pediatric field].
Okamoto K; Shino K; Fuke H; Watanabe K; Ozaki H
Jpn J Antibiot; 1982 Nov; 35(11):2545-54. PubMed ID: 6302336
[TBL] [Abstract][Full Text] [Related]
26. [The concentration of cefmenoxime after intravenous drip infusion in digestive organs and exudates from abdominal and thoracic cavities in human].
Ishiyama S; Katagiri S; Seo N; Yagi S; Iizawa H; Hoshikawa T; Hara T; Kameyama J; Tsukamoto M; Takahashi C
Jpn J Antibiot; 1985 Jun; 38(6):1643-7. PubMed ID: 3862882
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study of cefmenoxime in acute peritonitis: clinical effect and tissue concentration of cefmenoxime].
Hashimoto I; Sawada Y; Nakamura T; Mikami J; Bekki E; Abe H; Nakanishi M; Kasai Y
Jpn J Antibiot; 1983 Jun; 36(6):1544-52. PubMed ID: 6317906
[TBL] [Abstract][Full Text] [Related]
28. [Concentrations of cefmenoxime and cefotiam in the bile and gallbladder tissue following intravenous administration in patients with biliary tract diseases].
Shoda Y; Matsuyama S; Takarada A; Arai M; Nagashima K; Nakano G; Nakamura T; Kamisaka K; Matsuzawa T; Yoshino T
Jpn J Antibiot; 1986 May; 39(5):1259-72. PubMed ID: 3463776
[TBL] [Abstract][Full Text] [Related]
29. [Transfer of cefmenoxime to lung tissue and thoracic muscle in thoracic surgery].
Teranishi Y; Tazaki T; Abe T; Honda M; Ohishi A; Endoh Y; Konno O; Usuba A; Inoue H; Shoji M
Jpn J Antibiot; 1986 Jan; 39(1):127-32. PubMed ID: 3457962
[TBL] [Abstract][Full Text] [Related]
30. [A study on the penetration of cefmenoxime into bile and gallbladder tissues and the pathological changes of inflamed tissues].
Tsuburaya H; Ando Y; Kimizima I; Watanabe I; Abe R; Funayama T; Kawaguchi Y
Jpn J Antibiot; 1986 Sep; 39(9):2381-5. PubMed ID: 3467080
[TBL] [Abstract][Full Text] [Related]
31. [Clinical experience with cefmenoxime (CMX) in complicated urinary tract infections].
Minami Y; Kanda S; Matsuo R; Sakai H; Kamemoto H; Hisamatsu A; Maruta N; Johdai A; Shimomae H; Watanabe Y
Hinyokika Kiyo; 1985 Jun; 31(6):1077-84. PubMed ID: 3864365
[TBL] [Abstract][Full Text] [Related]
32. [The transfer of cefmenoxime into the retroperitoneal fluid after extensive panhysterectomy].
Yamamoto T; Yasuda J; Kanao M; Okada H
Jpn J Antibiot; 1984 Sep; 37(9):1599-602. PubMed ID: 6096582
[TBL] [Abstract][Full Text] [Related]
33. [A study on transference of cefmenoxime into the cerebrospinal fluid].
Shibata Y; Nogaki H; Ishida K; Kawaguchi T
Jpn J Antibiot; 1985 Jan; 38(1):45-8. PubMed ID: 3857362
[TBL] [Abstract][Full Text] [Related]
34. [Clinical studies with cefmenoxime in the field of pediatrics].
Takimoto M; Yoshioka H; Maruyama S; Sanae N; Nagamatsu I
Jpn J Antibiot; 1982 Oct; 35(10):2379-83. PubMed ID: 6306289
[TBL] [Abstract][Full Text] [Related]
35. [Clinical and pharmacokinetic evaluation of cefodizime in children].
Hirabayashi Y; Higashino H; Kino M; Nobori U; Okazaki H; Kitamura N; Kobayashi Y
Jpn J Antibiot; 1989 Jun; 42(6):1366-80. PubMed ID: 2795860
[TBL] [Abstract][Full Text] [Related]
36. [Concentrations of cefotiam and cefmenoxime in the human bone marrow blood and osseous tissue].
Kumano O; Ohshima S; Yamaguchi H; Hiraoka T; Yamasaki H
Jpn J Antibiot; 1984 Mar; 37(3):309-17. PubMed ID: 6330397
[TBL] [Abstract][Full Text] [Related]
37. [Clinical studies on cefmenoxime in pediatric field].
Yanagisawa K; Yanagisawa K; Hoshina H; Ichihashi H
Jpn J Antibiot; 1982 Oct; 35(10):2414-22. PubMed ID: 6306293
[TBL] [Abstract][Full Text] [Related]
38. [Clinical evaluation of cefmenoxime in chronic complicated urinary tract infection].
Ashiki A; Sudo Y; Suzuki T; Yamato K; Tsukui A; Hamada W; Kusumi Y
Jpn J Antibiot; 1985 Jan; 38(1):49-61. PubMed ID: 3857363
[TBL] [Abstract][Full Text] [Related]
39. [Pharmacokinetic and clinical studies on cefmenoxime in newborn infants].
Nakazawa S; Sato H; Hirama Y; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Nakanishi Y; Chikaoka H; Niino K
Jpn J Antibiot; 1989 Dec; 42(12):2627-40. PubMed ID: 2614918
[TBL] [Abstract][Full Text] [Related]
40. [Concentrations of cefmenoxime in human bone marrow blood and osseous tissue].
Kurata Y; Kushimoto H; Hoshi Y; Yutani Y; Tajima K; Yanai N; Sumita M; Horisawa Y
Jpn J Antibiot; 1986 Sep; 39(9):2374-80. PubMed ID: 3467079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
